Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
British Journal of Haematology|March 22, 2001
Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?T Bachleitner-Hofmann, B Gisslinger, E Grumbeck, et al.European Journal of Haematology|January 26, 1999
The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia veraN Heis, C Rintelen, B Gisslinger, et al.American Journal of Hematology|December 22, 1999
Macrocytic anemia and thrombocytosis associated with thymoma: a case reportE Grumbeck, P Aiginger, B Gisslinger, et al.Leukemia & Lymphoma|April 1, 1994
MDR1 gene expression in chronic lymphocytic leukemiaJ Wallner, H Gisslinger, B Gisslinger, et al.Blood|April 21, 2001
Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptorH Gisslinger, R Kurzrock, B Gisslinger, et al.Leukemia|May 29, 2010
Deletions of the transcription factor Ikaros in myeloproliferative neoplasmsR Jäger, H Gisslinger, F Passamonti, et al.Leukemia|December 30, 2015
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteriaH Gisslinger, G Jeryczynski, B Gisslinger, et al.Leukemia|July 27, 2017
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational statusB Kubesova, S Pavlova, J Malcikova, et al.Leukemia|June 7, 2013
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyA Tefferi, E Rumi, G Finazzi, et al.Pageof 1